  | Pilard, C., RONCARATI, P., Ancion, M., Luyckx, M., Renard, M., Reynders, C., Lerho, T., Poulain, F., Bruyère, D., LEBEAU, A., Hendrick, E., Crake, R., Peiffer, R., Nokin, M.-J., Peulen, O., Delvenne, P., Hubert, P.* , & Herfs, M.*. (13 March 2025). RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells. Journal for ImmunoTherapy of Cancer, 13 (3), 010753. doi:10.1136/jitc-2024-010753  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
  | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., RONCARATI, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (25 October 2024). Enhancing immune response and preventing breast cancer spread by lowering methylglyoxal stress [Poster presentation]. Metabolism Contact Group Meeting. |
 | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., RONCARATI, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (17 September 2024). Investigating the effects of methylglyoxal stress on immune response to tumors [Paper presentation]. IMARS-15 Congress, Maastricht, Netherlands. |
 | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., RONCARATI, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (04 July 2024). EXAMINING THE INFLUENCE OF METHYLGLYOXAL STRESS ON THE IMMUNE RESPONSE TO TUMORS [Paper presentation]. 11th ISCAM Meeting. |
 | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (06 February 2024). Exploring the impact of methylglyoxal stress on tumor immunity [Poster presentation]. Séminaire Télévie 2024. |
 | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., RONCARATI, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (2024). Impact of Methylglyoxal stress on the immune system within the breast cancer environment [Poster presentation]. Giga Day. |
 | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., RONCARATI, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (2024). Scrutinizing the impact of methylglyoxal stress on tumor immune response [Poster presentation]. VIB conference : “**Recent insights into Immuno-Oncology (2nd edition)**”, Anvers, Belgium. |
 | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., RONCARATI, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (2024). Reducing Methylglyoxal Stress to Amplify Immune Response and Inhibit Breast Cancer Spread [Poster presentation]. BACR annual meeting. |
 | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (27 October 2023). Methylglyoxal stress : a novel role in tumor immunity ? [Poster presentation]. Annual Meeting of the Belgian Association for Cancer Research (BACR). |
 | Ancion, M., Luyckx, M., Renard, M., Reynders, C., Lerho, T., Bruyère, D., Hendrick, E., Pilard, C., RONCARATI, P., Herfs, M., & Hubert, P. (12 June 2023). Approach using "second generation" immune checkpoint inhibitors for the treatment of triple-negative breast cancer [Poster presentation]. EACR 2023, Turin, Italy. |
 | Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Luyckx, M., Renard, M., Delvenne, P., Hubert, P., & Herfs, M. (02 February 2023). Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV in carcinogenesis [Poster presentation]. Séminaire des chercheurs Télévie 2023. |
 | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., & Janji, B. (2023). Enhancement of anti-tumor immunity through interference with glycation stress in breast cancer [Poster presentation]. GIGA day. |
 | Bruyere, D., RONCARATI, P., Lebeau, A., Lerho, T., Poulain, F., Hendrick, E., Pilard, C., Reynders, C., Ancion, M., Luyckx, M., Renard, M., Jacob, Y., Twizere, J.-C., Peiffer, R., Peulen, O., Delvenne, P., Hubert, P., McBride, A., Gillet, N., ... Herfs, M. (2023). Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair. Theranostics, 13 (3), 1130 - 1149. doi:10.7150/thno.78091 Peer Reviewed verified by ORBi |
 | Reynders, C., Roncarati, P., Ancion, M., Lerho, T., Bruyère, D., Delvenne, P., Hubert, P., & Herfs, M. (29 September 2022). Caractérisations histopathologiques des cancers œsophagiennes et potentiel implication des infections par HPV de haut-risques [Paper presentation]. Conférence annuelle de l'Association Francophone pour l'étude des Infections à Papillomavirus et Polyomavirus 2022, France. |
 | Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Pilard, C., Bruyère, D., Hendrick, E., Delvenne, P., Hubert, P., & Herfs, M. (09 September 2022). Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV in carcinogenesis [Poster presentation]. INTERUNIVERSITY PHD STUDENT DAY. |
 | Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Pilard, C., Hendrick, E., Bruyère, D., Delvenne, P., Hubert, P., & Herfs, M. (06 September 2022). Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV infections in carcinogenesis [Poster presentation]. GIGA-Day 2022. |
 | Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (September 2022). Immunosuppressive effect of methylglyoxal stress in breast cancer [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Belgium. |
 | Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim, M., Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (21 June 2022). Methylglyoxal reshapes breast tumor immune microenvironment [Poster presentation]. European association for cancer research congress 2022, Séville, Spain. |
Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Bruyère, D., Hendrick, E., Pilard, C., Delvenne, P., Hubert, P., & Herfs, M. (29 April 2022). Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV in carcinogenesis [Paper presentation]. Séminaire du GIGA-Cancer, Belgium. |
 | Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Hendrick, E., Bruyère, D., Pilard, C., Delvenne, P., Hubert, P., & Herfs, M. (08 April 2022). Histopathological characterization of esophageal cancers and potential role of high-risk HPV infections [Poster presentation]. Séminaire des chercheurs Télévie 2022, Belgium. |
 | Lebeau, A.* , Bruyère, D.* , RONCARATI, P., Peixoto, P., Hervouet, E., COBRAIVILLE, G., Taminiau, B., Masson, M., Gallego, C., Mazzucchelli, G., Smargiasso, N., Fleron, M., Baiwir, D., Hendrick, E., Pilard, C., Lerho, T., Reynders, C., Ancion, M., GREIMERS, R., ... Herfs, M. (28 February 2022). HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources. Nature Communications, 13 (1), 1076. doi:10.1038/s41467-022-28724-8 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (2022). Methylglyoxal regulates the recruitment of tumor-infiltrating immunosuppressive cells in breast cancer [Poster presentation]. PhD Day UNamur 2022, Belgium. |
 | Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Pilard, C., Bruyère, D., Hendrick, E., Delvenne, P., Hubert, P., & Herfs, M. (14 December 2021). Histopathological characterization of esophageal cancers and potential role of high-risk HPV infections [Poster presentation]. Giga Cancer Day 2021. |
 | Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Bruyère, D., Hendrick, E., Pilard, C., Hubert, P., Delvenne, P., & Herfs, M. (01 October 2021). Caractérisation histopathologique des cancers œsophagiens et potentiel rôle des HPV [Paper presentation]. Conférence annuelle de l'Association Francophone pour l'étude des Infections à Papillomavirus et Polyomavirus, France. |
Wissocq, T., Hubert, P., Tiamiou, A., Hasmim, M., Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (May 2021). Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape [Poster presentation]. 4th METABOLISM & CANCER SYMPOSIUM VIRTUAL MEETING, Bordeaux, France. |
 | Bruyère, D., Monnien, F., Colpart, P., RONCARATI, P., Vuitton, L., Hendrick, E., Lepinoy, A., Luquain, A., Pilard, C., Lerho, T., Molimard, C., Maingon, P., Arnould, L., Bone-Lepinoy, M.-C., Dusserre, L., Martin, L., Reynders, C., Ancion, M., Peiffert, D., ... Herfs, M. (2021). Treatment algorithm and prognostic factors for patients with stage I–III carcinoma of the anal canal: a 20-year multicenter study. Modern Pathology, 34, 116-130. doi:10.1038/s41379-020-0637-6 Peer Reviewed verified by ORBi |
 | Pilard, C.* , Ancion, M.* , Delvenne, P., JERUSALEM, G., Hubert, P., & Herfs, M. (2021). Cancer immunotherapy: it’s time to better predict patients’ response. British Journal of Cancer, 125(7), 927-938. doi:10.1038/s41416-021-01413-x Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Hubert, P., RONCARATI, P., Demoulin, S., Pilard, C., Ancion, M., Reynders, C., Lerho, T., Bruyère, D., Lebeau, A., Radermecker, C., Meunier, M., Nokin, M.-J., Hendrick, E., Peulen, O., Delvenne, P., & Herfs, M. (2021). Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Journal for ImmunoTherapy of Cancer, 9 ((3)), 001966. doi:10.1136/jitc-2020-001966 Peer Reviewed verified by ORBi |
Pilard, C., RONCARATI, P., Hendrick, E., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (03 November 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Paper presentation]. Cytokines 2020, Seattle (Virtual), United States. |
 | LAMBERT, V.* , hansen, S.* , Schoumacher, M.* , Lecomte, J., Leenders, J., Hubert, P., Herfs, M., Blacher, S., Carnet, O., Yip, C., BLAISE, P., DUCHATEAU, E., LOCHT, B., THYS, M., CAVALIER, E., GOTHOT, A., Govaerts, B., RAKIC, J.-M., Noël, A.* , & De Tullio, P.*. (2020). Pyruvate dehydrogenase kinase/lactate axis: a therapeutic target for neovascular age-related macular degeneration identified by metabolomics. Journal of Molecular Medicine. doi:10.1007/s00109-020-01994-9 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Pilard, C., RONCARATI, P., Hendrick, E., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (03 October 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. 7th Immunotherapy of Cancer Conference (ITOC7), Munich (Virtual), Germany. |
 | Pilard, C., RONCARATI, P., Hendrick, E., Lebeau, A., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (01 October 2020). P08.03 Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy. Journal for ImmunoTherapy of Cancer, 8 (Suppl 2), 50-A51. doi:10.1136/jitc-2020-ITOC7.99 |
 | Pilard, C., RONCARATI, P., Hendrick, E., Lebeau, A., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (07 February 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. BACR 2020, Jette, Belgium. |
Wissocq, T., Hubert, P., Caprasse, M., Nokin, M.-J., Noman, M. Z., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (07 February 2020). Methylglyoxal stress contributes to immunosuppression in breast cancer [Poster presentation]. Association Belge pour l'Etude du Cancer "A.B.E.C", Bruxelles, Belgium. |
 | Pilard, C., RONCARATI, P., Hendrick, E., Lebeau, A., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (29 January 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. Télévie Seminar 2020, Bruxelles, Belgium. |
 | Staumont, B., Jamakhani, M., Costa, C., Vandermeers, F., Sriramareddy, S. N., Redouté, G., Mascaux, C., Delvenne, P., Hubert, P., Safari, R., & Willems, L. (2020). TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma. Cancers, 12 (6), 1484. doi:10.3390/cancers12061484 Peer Reviewed verified by ORBi |
 | Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (21 May 2019). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. Immunology Day 2019, Liège, Belgium. |
 | Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (01 February 2019). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. BACR 2019, Anvers, Belgium. |
 | Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (28 January 2019). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. Télévie Seminar 2019, Gembloux, Belgium. |
 | Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (13 September 2018). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. GIGA-Cancer Day 2018, Liège, Belgium. |
 | Bruyère, D., Lebeau, A., RONCARATI, P., Hendrick, E., Masson, M., Twizere, J.-C., Pilard, C., Hubert, P., DELVENNE, P., & Herfs, M. (30 May 2018). Deciphering the radiosensitivity of HPV-positive tumors [Poster presentation]. 5th meeting on emerging issues in oncogenic virus research, San Pietro in Bevagna, Italy. |
 | Bruyère, D., Lebeau, A., RONCARATI, P., Hendrick, E., Masson, M., Twizere, J.-C., Pilard, C., Hubert, P., DELVENNE, P., & Herfs, M. (28 May 2018). Deciphering the radiosensitivity of HPV-positive tumors [Poster presentation]. EDT-Immunology day 2018, Liège, Belgium. |
Lebeau, A., Bruyère, D., Hendrick, E., Pilard, C., RONCARATI, P., TAZIAUX, S., Hubert, P., Delvenne, P., & Herfs, M. (28 May 2018). HPV-related innate peptide inhibition promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Immunology day 2018, Liège, Belgium. |
Lebeau, A., Bruyère, D., Hendrick, E., Pilard, C., RONCARATI, P., TAZIAUX, S., Hubert, P., Delvenne, P., & Herfs, M. (01 February 2018). HPV-related innate peptide inhibition promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Annual Televie seminar, Bruxelles, Belgium. |
 | Collignon, E.* , Canale, A.* , Al Wardi, C., Bizet, M., Calonne, E., Dedeurwaerder, S., Garaud, S., Naveaux, C., Barham, W., Wilson, A., Bouchat, S., Hubert, P., Van Lint, C., Yull, F., Sotiriou, C., Willard-Gallo, K., Noël, A.* , & Fuks, F.*. (2018). Immunity drives TET1 regulation in cancer through NF-kappaB. Science Advances, 4 (6), 7309. doi:10.1126/sciadv.aap7309 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Herfs, M., RONCARATI, P., KOOPMANSCH, B., Peulen, O., Bruyère, D., Lebeau, A., Hendrick, E., Hubert, P., PONCIN, A., Penny, W., Piazzon, N., Monnien, F., Guenat, D., Mougin, C., Prétet, J.-L., Vuitton, L., SEGERS, K., LAMBERT, F., BOURS, V., ... Delvenne, P. (2018). A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalized medicine. British Journal of Cancer, 118(10), 1302-1312. doi:10.1038/s41416-018-0049-2 Peer Reviewed verified by ORBi |
 | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (07 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. SF Nano Annual Meeting 2017, Bordeaux, France. |
 | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (05 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 4th SF Nano Annual Meeting, Bordeaux, France. |
 | Lechanteur, A., Furst Tania, Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (25 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 1st SPLC-Controlled Release Society, Santiago de Compostela, Spain. |
 | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (04 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 2nd European Conference on Pharmaceutics: Drug Delivery, Krakow, Poland. |
 | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Piel, G., & Hubert, P. (2017). Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment. Molecular Pharmaceutics. doi:10.1021/acs.molpharmaceut.6b01154 Peer Reviewed verified by ORBi |
Lebeau, A., Bruyère, D., RONCARATI, P., DELVENNE, P., Hubert, P., & Herfs, M. (01 February 2017). HPV-mediated innate peptide down-regulation promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. GIGA Day 2017, Liège, Belgium. |
Staumont, B., Costa, C., Vandermeers, F., Neelature Sriramareddy, S., Mascaux, C., Scherpereel, A., DUYSINX, B., LOUIS, R., DELVENNE, P., Hubert, P., & Willems, L. (01 February 2017). EGFR tyrosine kinase inhibitors overcome resistance to chemotherapy in malignant pleural mesothelioma [Poster presentation]. GIGA conference day: New insights into the hallmarks of cancer. |
 | Herfs, M., Longuespée, R., Quick, C., RONCARATI, P., Suarez-Carmona, M., Hubert, P., Lebeau, A., Bruyère, D., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Lai, K., Dunn, A., Obregon, F., Yang, E., De Pauw, E., Crum, C., & Delvenne, P. (2017). Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma. Journal of Pathology, 241, 522-533. doi:10.1002/path.4858 Peer Reviewed verified by ORBi |
Lebeau, A., Bruyère, D., RONCARATI, P., Delvenne, P., Hubert, P., & Herfs, M. (08 December 2016). HPV-mediated innate peptide down-regulation promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Televie Seminar, Bruxelles, Belgium. |
Lechanteur, A., Furst, T., Evrard, B., DELVENNE, P., Hubert, P., & Piel, G. (27 September 2016). FINDING THE RIGHT BALANCE BETWEEN EFFECTIVENESS, TOXICITY AND VAGINAL DIFFUSION OF siRNA LIPOPLEXES FOR CERVICAL CANCER TREATMENT [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France. |
 | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (August 2016). PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. European Journal of Pharmaceutical Sciences, 93, 493-593. doi:10.1016/j.ejps.2016.08.058 Peer Reviewed verified by ORBi |
Staumont, B., Costa, C., Vandermeers, F., Neelature Sriramareddy, S., Mascaux, C., Scherpereel, A., DUYSINX, B., LOUIS, R., DELVENNE, P., Hubert, P., & Willems, L. (2016). EGFR tyrosine kinase inhibitors overcome resistance to chemotherapy in malignant pleural mesothelioma. In Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016. Peer reviewed |
 | Hubaux, R., Vandermeers, F., Cosse, J.-P., Crisanti, C., Kapoor, V., Albelda, S. M., Mascaux, C., Delvenne, P., Hubert, P., & Willems, L. (19 October 2015). Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models. ERJ Open Research, 1 (2), 00028. doi:10.1183/23120541.00028-2015 Peer Reviewed verified by ORBi |
| Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (28 May 2015). DEVELOPMENT OF LIPOPLEXES FOR A TOPICAL TREATMENT OF HPV16 INDUCED LESIONS: In vitro and ex vivo studies [Paper presentation]. 18th Forum of Pharmaceutical Sciences, Blankenberg, Belgium. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (13 May 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of HPV16 induced lesions [Paper presentation]. GIGA-Cancer Day 2015, Liege, Belgium. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (14 April 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics Drug Delivery, Reims, France. |
 | Lechanteur, A.* , Furst, T.* , Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (16 February 2015). Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions. International Journal of Pharmaceutics, 483, 268-277. doi:10.1016/j.ijpharm.2015.02.041 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (11 February 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of cervical (pre)neoplastic lesions [Poster presentation]. Séminaire des chercheurs Télévie 2015, Bruxelles, Belgium. |
 | Demoulin, S., Herfs, M., SOMJA, J., RONCARATI, P., Delvenne, P., & Hubert, P. (2015). HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells. International Journal of Cancer, 137, 345-358. doi:10.1002/ijc.29389 Peer Reviewed verified by ORBi |
 | Suarez-Carmona, M., Hubert, P., Delvenne, P., & Herfs, M. (2015). Defensins: « simple » antimicrobial peptides or broad-spectrum molecules ? Cytokine and Growth Factor Reviews, 26, 361-370. doi:10.1016/j.cytogfr.2014.12.005 Peer Reviewed verified by ORBi |
| Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (2015). Anti-E6/E7/MCL-1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France. |
 | Suarez-Carmona, M., Bourcy, M., LESAGE, J., Leroi, N., Syne, L., Blacher, S., Hubert, P., Erpicum, C., Foidart, J.-M., Delvenne, P., Birembaut, P., Noël, A., Polette, M., & Gilles, C. (2015). Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment. Journal of Pathology, 236 (4), 491-504. doi:10.1002/path.4546 Peer Reviewed verified by ORBi |
 | Shiva Shankar, T. V., Sulka, B., Hubert, P., Hubaux, R., Delvenne, P., Pendeville-Samain, H., Boittiaux, I., Lambert, D. M., Wouters, J., Maillard, C., Blacher, S., Noël, A., Struman, I., & Willems, L. (2015). N-Hydroxy-6-(5-Nitro- Naphtalimide)-Hexanamide Inhibits Lysine Deacetylation, Mitigates Angiogenesis and Reduces Tumor Growth. Journal of Cancer Sciences, 2 (2), 0-11. Peer reviewed |
 | Demoulin, S., SOMJA, J., duray, A., guenin, S., RONCARATI, P., DELVENNE, P., Herfs, M.* , & Hubert, P.*. (2015). Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion. Oncoimmunology, 6. doi:10.1080/2162402X.2015.1008334 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Herfs, M., SOMJA, J., Howitt, B. E., Suarez-Carmona, M., KUSTERMANS, G., Hubert, P., DOYEN, J., GOFFIN, F., Kridelka, F., Crum, C. P., & Delvenne, P. (2015). Unique recurrence patterns of cervical intraepithelial neoplasia following excision of the squamo-columnar junction. International Journal of Cancer, 136, 1043-1052. doi:10.1002/ijc.28978 Peer Reviewed verified by ORBi |
 | Mirkovic, J., Howitt, B., RONCARATI, P., Demoulin, S., Suarez-Carmona, M., Hubert, P., Mckeon, F., Xian, W., Delvenne, P., Crum, C. P., & Herfs, M. (2015). Carcinogenic HPV infection in the cervical squamo-columnar junction. Journal of Pathology, 236, 265-271. doi:10.1002/path.4533 Peer Reviewed verified by ORBi |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 November 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (20 October 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 3rd NanoFar Autumn School, Louvain, Belgium. |
| Lechanteur, A., Furst, T., Kanber, E., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (04 October 2014). Development and optimization of pegylated lipoplexes for vaginal application [Paper presentation]. SFNano Workshop 2014, Porto, Portugal. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (27 August 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES TO BE INCORPORATED INTO MUCOADHESIVE HEC-SPONGES [Poster presentation]. Translational Nanomedicine, International Meeting, Angers, France. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (19 May 2014). ASSOCIATION OF LIPOSOMES AND siRNA FOR A LOCAL TREATMENT OF CERVICAL CANCER [Poster presentation]. GIGA-Cancer Day 2014. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 April 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES WITH siRNA ANTI E6/E7 ONCOPROTEINS FOR THE TREATMENT OF HPV CANCERS [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lisbonne, Portugal. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (16 February 2014). Development of PEG-coated lipoplexes with siRNA anti-E6/E7 oncoproteins to be incorporated into mucoadhesive HEC-sponges for the treatment of HPV cancers [Poster presentation]. 10th International Conference and Workshop on Biological Barriers, Saarbrucken, Germany. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (16 February 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. 10th International conference and workshop on Biological Barriers. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (27 January 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. GIGA-Day 2014. |
 | Hubert, P.* , Herman, L.* , RONCARATI, P., Maillard, C., Renoux, V., Demoulin, S., Erpicum, C., Foidart, J.-M., Boniver, J., Noël, A., Delvenne, P., & Herfs, M. (2014). Altered alpha-defensin 5 expression in cervical squamocolumnar junction: implication in the formation of a viral/tumour-permissive microenvironment. Journal of Pathology, 234 (4), 464-77. doi:10.1002/path.4435 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Suarez-Carmona, M., Hubert, P., Gonzalez, A., Duray, A., RONCARATI, P., Erpicum, C., Boniver, J., Castronovo, V., Noël, A., Saussez, S., Peulen, O., Delvenne, P., & Herfs, M. (2014). DeltaNp63 isoform-mediated beta-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma. Oncotarget, 5 (7), 1856-1868. doi:10.18632/oncotarget.1819 Peer Reviewed verified by ORBi |
 | Shostak, K., Zhang, X., Hubert, P., Göktuna, S., Jiang, Z., Klevernic, I., Hildebrand, J., Roncarati, P., Hennuy, B., Ladang, A., SOMJA, J., Gothot, A., Close, P., Delvenne, P., & Chariot, A. (2014). NF-kappaB-induced KIAA1199 promotes survival through EGFR signalling. Nature Communications, 5, 5232. doi:10.1038/ncomms6232 Peer Reviewed verified by ORBi |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (05 December 2013). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. Séminaire des chercheurs du Télévie 2014. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (03 December 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. 28ième Journées Scientifiques du GTRV, Angers, France. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (02 December 2013). Development of peggylated lipoplexes with siRNA anti-E6/E7 oncoproteins for the treatment og cancers induced by HPV [Poster presentation]. GTRV, Orléans, France. |
Demoulin, S., Somja, J., Herfs, M., RONCARATI, P., Delvenne, P., & Hubert, P. (December 2013). Implication of plasmacytoid dendritic cells in the malignant transformation of cervical epithelial metaplasia [Poster presentation]. 4th International Workshop on plasmacytoid dendritic cells, Paris, France. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 October 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. Dix-septième forum des sciences pharmaceutiques. |
Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 June 2013). Développement et optimisation de vecteur de type lipoplexe pour une approche thérapeutique antisens dans le cadre de lésions induites par HPV [Paper presentation]. Séminaire C.I.R.M. |
 | Renauld, J., Johnen, N., Hubert, P., Thelen, N., Cloes, M., & Thiry, M. (28 January 2013). Whole organ culture in rotating bioreactor: the rat embryonic inner ear [Poster presentation]. GIGA-Day, Liège, Belgium. |
 | Guenin, S., Mouallif, M., Hubert, P., Jacobs, N., Krusy, N., Duray, A., Ennaji, M. M., Saussez, S., & Delvenne, P. (2013). Interleukin-32 expression is associated with a poorer prognosis in head and neck squamous cell carcinoma. Molecular Carcinogenesis, 53 (8), 667-673. doi:10.1002/mc.21996 Peer Reviewed verified by ORBi |
 | Reschner, A., BONTEMS, S., Le Gac, S., Lambermont, J., De Francq, E., Hubert, P., Moucheron, C., Kirsch-De Mesmaeker, A., Raes, M., Piette, J., & Delvenne, P. (2013). Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53. Gene Therapy, 20 (4), 435-443. doi:10.1038/gt.2012.54 Peer Reviewed verified by ORBi |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Poster presentation]. Cancer GIGA-Day 2013, liège, Belgium. |
 | Demoulin, S., Herfs, M., Delvenne, P., & Hubert, P. (2013). Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms. Journal of Leukocyte Biology, 93 (3), 343-352. doi:10.1189/jlb.0812397 Peer Reviewed verified by ORBi |
 | Somja, J., Demoulin, S., RONCARATI, P., Herfs, M., BLETARD, N., Delvenne, P., & Hubert, P. (2013). Dendritic cells in Barrett's esophagus carcinogenesis: an inadequate microenvironment for antitumor immunity? American Journal of Pathology, 182, 2168-2179. doi:10.1016/j.ajpath.2013.02.036 Peer Reviewed verified by ORBi |
| Lechanteur, A., Evrard, B., Delvenne, P., RONCARATI, P., Hubert, P., & Piel, G. (November 2012). Development and optimization of lipoplex vectors for an antisens therapeutic approach in the context of HPV induced lesions [Poster presentation]. Ecole doctorale en cancérologie expérimentale, liège, Belgium. |
| Furst, T., Lechanteur, A., Evrard, B., Delvenne, P., Hubert, P., Piette, M., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar 1st Autumn School, Angers, France. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar Automn School, Angers, France. |
 | Costa, C., Vandermeers, F., Reddy, N. S., Mascaux, C., Scherpereel, A., Delvenne, P., Hubert, P., & Willems, L. (13 September 2012). The role of TGF-alpha in the resistance to mesothelioma chemotherapy [Poster presentation]. 11th International Conference of the International Mesothelioma Interest Group (iMig 2012), Boston, United States - Massachusetts. |
Costa, C., Vandermeers, F., Reddy, N. S., Hubert, P., & Willems, L. (2012). The role of TGF-alpha in resistance to mesothelioma chemotherapy. |
 | Herfs, M., Hubert, P., POIRRIER, A.-L., Vandevenne, Renoux, V., Habraken, Y., Cataldo, D., Boniver, J., & Delvenne, P. (2012). Proinflammatory Cytokines Induce Bronchial Hyperplasia and Squamous Metaplasia in Smokers: Implications for chronic obstructive pulmonary disease therapy. American Journal of Respiratory Cell and Molecular Biology, 47 (1), 67-79. doi:10.1165/rcmb.2011-0353OC Peer Reviewed verified by ORBi |
 | Demoulin, S., RONCARATI, P., Delvenne, P., & Hubert, P. (2012). Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34+ hematopoietic progenitor cells: use of IL-3. Experimental Hematology, 40 (4), 268-278. doi:10.1016/j.exphem.2012.01.002 Peer reviewed |
Demoulin, S., RONCARATI, P., Delvenne, P., & Hubert, P. (December 2011). Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34+ hematopoietic progenitor cells: use of IL-3 [Poster presentation]. 3ème Atelier International "Cellules Dendritiques Plasmacytoïdes et Réponses Immunes", Paris, France. |
 | Costa, C., Vandermeers, F., Reddy, N. S., Mascaux, C., Hubert, P., Delvenne, P., & Willems, L. (2011). Thérapie du mésothéliome pleural : compréhension des mécanismes de résistance à la chimiothérapie. |
Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (14 June 2011). Topical application of liposomes: parameters influencing their effectiveness [Poster presentation]. PharmSciFair, Prague, Czechia. |
| Gillet, A., Compère, P., Lecomte, F., Hubert, P., Ducat, E., Evrard, B., & Piel, G. (June 2011). Liposome surface charge influence on skin penetration behaviour. International Journal of Pharmaceutics, 411 (1-2), 223-231. doi:10.1016/j.ijpharm.2011.03.049 Peer Reviewed verified by ORBi |
Jost, M., Frankenne, F., Maillard, C., Hubert, P., Herman, L., Delvenne, P., Piette, M., Coia, I., Evrard, B., Lecomte, F., Hubert, P., Englert, Y., Bossens, M., van Pachterbeke, C., GOFFIN, F., Doyen, J., Kridelka, F., Snoeck, R., & FOIDART, J.-M. (20 May 2011). From the Clinics to the Bench and back to the Clinics: design of a medical treatment for Cervical Intraepithelial Neoplasia (CIN) [Paper presentation]. GIGA-Cancer Day, Liège, Belgium. |
Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (12 May 2011). Parameters influencing the skin penetration effectiveness of liposomes [Paper presentation]. 15th Forum of Pharmaceutical Sciences, Spa, Belgium. |
Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (28 March 2011). Evaluation of parameters affecting skin penetration behaviour of liposomes [Poster presentation]. Skin Forum 12th Annual Meeting, Frankfurt, Germany. |
 | Herfs, M., Hubert, P., Moutschen, M., & Delvenne, P. (07 January 2011). Mucosal junctions: open doors to HPV and HIV infections? Trends in Microbiology, 19 (3), 114-120. doi:10.1016/j.tim.2010.12.006 Peer Reviewed verified by ORBi |
Demoulin, S., Herfs, M., Somja, J., Delvenne, P., Hubert, P., & RONCARATI, P. (2011). Implication of plasmacytoid dendritic cells in the malignant transformation of cervical epithelial metaplasia [Poster presentation]. miRNA symposium, Namur, Belgium. |
 | Gillet, A., Lecomte, F., Hubert, P., Ducat, E., Evrard, B., & Piel, G. (2011). Skin penetration behaviour of liposomes as a function of their composition. European Journal of Pharmaceutics and Biopharmaceutics, 79, 43-53. doi:10.1016/j.ejpb.2011.01.011 Peer Reviewed verified by ORBi |
Demoulin, S., Somja, J., Herfs, M., Delvenne, P., & Hubert, P. (2011). Implication of plasmacytoid dendritic cells in the malignant transformation of cervical epithelial metaplasia [Poster presentation]. GIGA Cancer Day, Liège, Belgium. |
Gillet, A., Lecomte, F., Hubert, P., Evrard, B., & Piel, G. (October 2010). Interest of vesicular systems in dermal drug delivery [Poster presentation]. 2nd Innovation in Drug Delivery, Aix-en-Provence, France. |
Demoulin, S., Herfs, M., Somja, J., RONCARATI, P., Boniver, J., Delvenne, P., & Hubert, P. (September 2010). Implication of plasmacytoid dendritic cells in the malignant transformation of cervical epithelial metaplasia [Poster presentation]. Cell Symposium on Inflammation and Disease, Lisbonne, Portugal. |
Gillet, A., Lecomte, F., Hubert, P., Evrard, B., & Piel, G. (06 July 2010). Penetration mechanism of classical and deformable liposomes through pig ear skin [Poster presentation]. Skin Forum 11th Annual Meeting, Edinburgh, United Kingdom. |
 | Herman, L., Hubert, P., Herfs, M., Kustermans, G., Henrotin, Y., Bousarghin, L., Boniver, J., & Delvenne, P. (2010). The L1 major capsid protein of HPV16 differentially modulates APC trafficking according to the vaccination or natural infection context. European Journal of Immunology, 40 (11), 3075-84. doi:10.1002/eji.201040571 Peer Reviewed verified by ORBi |
Demoulin, S., Somja, J., Herfs, M., Delvenne, P., & Hubert, P. (2010). Implication of plasmacytoid dendritic cells in the malignant transformation of cervical epithelial metaplasia [Poster presentation]. GIGA Cancer Day, Liège, Belgium. |
Mignon, B., Hubert, P., Defaweux, V., Cambier, L., Baldo, A., Mathy, A., & Tabart, J. (2010). Cytokinic response and MHC class II expression in feline dendritic cells exposed to Microsporum canis components [Paper presentation]. 24th Congress of the European Society of Veterinary Dermatology - European College of Veterinary Dermatology (ESVD-ECVD), Firenze, Italy. |
Hubert, P., Doyen, J., Capelle, X., Arafa, M., Renoux, V., Bisig, B., Seidel, L., Evrard, B., Bousarghin, L., Gerday, C., Boniver, J., Foidart, J.-M., Delvenne, P., & Jacobs, N. (2010). Local applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesions. American Journal of Reproductive Immunology, 64 (2), 126-136. doi:10.1111/j.1600-0897.2010.00834.x Peer Reviewed verified by ORBi |
 | Herfs, M., Hubert, P., Suarez-Carmona, M., Reschner, A., Saussez, S., Berx, G., Savagner, P., Boniver, J., & Delvenne, P. (2010). Regulation of p63 Isoforms by Snail and Slug Transcription Factors in Human Squamous Cell Carcinoma. American Journal of Pathology, 176 (4), 1941-1949. doi:10.2353/ajpath.2010.090804 Peer Reviewed verified by ORBi |
 | Duray, A., Demoulin, S., Hubert, P., Delvenne, P., & Saussez, S. (2010). Immune suppression in head and neck cancers: a review. Clinical and Developmental Immunology, 2010, 701657. doi:10.1155/2010/701657 Peer Reviewed verified by ORBi |
 | Herfs, M., Hubert, P., & Delvenne, P. (June 2009). Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? Trends in Molecular Medicine, 15 (6), 245-253. doi:10.1016/j.molmed.2009.04.002 Peer Reviewed verified by ORBi |
 | Herfs, M., Herman, L., Hubert, P., Minner, F., Arafa, M. M. M., Roncarati, P., Henrotin, Y., Boniver, J., & Delvenne, P. (April 2009). High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells. Cancer Immunology, Immunotherapy, 58 (4), 603-614. doi:10.1007/s00262-008-0584-4 Peer Reviewed verified by ORBi |
 | Cloosen, S., Caberg, J.-H., Huls, M. B., Vanderlocht, J., Senden-Gilsbers, B. L. M. G., Roncarati, P., Hubert, P., Delvenne, P., Germeraad, W. T. V., & Bos, G. M. J. (February 2009). Surface Mucin-1 does not play a role in dendritic cell migration. Molecular Immunology, 46 (4), 738-742. doi:10.1016/j.molimm.2008.07.033 Peer Reviewed verified by ORBi |
 | Caberg, J.-H., Hubert, P., Herman, L., Herfs, M., Roncarati, P., Boniver, J., & Delvenne, P. (January 2009). Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunology, Immunotherapy, 58 (1), 39-47. doi:10.1007/s00262-008-0522-5 Peer Reviewed verified by ORBi |
 | Vandermeers, F., Hubert, P., Delvenne, P., Mascaux, C., Grigoriu, B., Burny, A., Scherpereel, A., & Willems, L. (2009). Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clinical Cancer Research, 15 (8), 2818-28. doi:10.1158/1078-0432.CCR-08-1579 Peer Reviewed verified by ORBi |
Noël, A., Herman, L., Hubert, P., Delvenne, P., Boniver, J., Evrard, B., Delattre, L., Frankenne, F., & Foidart, J.-M. (27 November 2008). MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS COMPRISING CHEMOATTRACTANTS. |
 | Caberg, J.-H., Hubert, P., Begon, D., Herfs, M., Roncarati, P., Boniver, J., & Delvenne, P. (July 2008). Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis, 29 (7), 1441-7. doi:10.1093/carcin/bgn145 Peer Reviewed verified by ORBi |
 | Herfs, M., Hubert, P., Kholod, N., Caberg, J.-H., Gilles, C., Berx, G., Savagner, P., Boniver, J., & Delvenne, P. (May 2008). Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. American Journal of Pathology, 172 (5), 1391-402. doi:10.2353/ajpath.2008.071004 Peer Reviewed verified by ORBi |
 | Quatresooz, P., Pierard, C., Paquet, P., Hubert, P., Delvenne, P., & Pierard, G. (2008). Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues. European Journal of Dermatology, 18 (1), 6-10. doi:10.1684/ejd.2008.0303 Peer Reviewed verified by ORBi |
 | Reschner, A., Hubert, P., Delvenne, P., Boniver, J., & Jacobs, N. (2008). Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clinical and Experimental Immunology, 152 (2), 219-26. doi:10.1111/j.1365-2249.2008.03624.x Peer Reviewed verified by ORBi |
 | Hubert, P., Jacobs, N., Caberg, J.-H., Boniver, J., & Delvenne, P. (October 2007). The cross-talk between dendritic and regulatory T cells: good or evil? Journal of Leukocyte Biology, 82 (4), 781-94. doi:10.1189/jlb.1106694 Peer Reviewed verified by ORBi |
 | Herman, L., Hubert, P., Caberg, J.-H., Evrard, B., Kedzia, W., Boniver, J., & Delvenne, P. (July 2007). MIP3 alpha stimulates the migration of Langerhans cells in models of human papillomavirus (HPV)-associated (pre)neoplastic epithelium. Cancer Immunology, Immunotherapy, 56 (7), 1087-1096. doi:10.1007/s00262-006-0255-2 Peer Reviewed verified by ORBi |
 | Delvenne, P., Goffin, F., Kridelka, F., Arafa, M., Carberg, J., Herfs, M., Herman, L., Hubert, P., Jacobs, N., Kholod, N., Foidart, J.-M., & Boniver, J. (2007). La cancer du col utérin: une infection par HPV qui tourne mal. Tempo Médical. |
 | Delvenne, P., Herman, L., Kholod, N., Caberg, J.-H., Herfs, M., Boniver, J., Jacobs, N., & Hubert, P. (2007). Role of hormone cofactors in the human papillomavirus-induced carcinogenesis of the uterine cervix. Molecular and Cellular Endocrinology, 264 (1-2), 1-5. doi:10.1016/j.mce.2006.10.014 Peer Reviewed verified by ORBi |
 | Hubert, P., Herman, L., Maillard, C., Caberg, J.-H., Nikkels, A., Pierard, G., Foidart, J.-M., Noël, A., Boniver, J., & Delvenne, P. (2007). Defensis induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo. FASEB Journal, 21 (11), 2765-75. doi:10.1096/fj.06-7646com Peer Reviewed verified by ORBi |
 | Hubert, P., Doyen, J., Chapelle, X., Evrard, B., Gerday, C., Boniver, J., Foidart, J.-M., & Jacobs, N. (2007). Phase I/IIclinical trial of local GM-CSF application in patients with cervical HPV-associated low grade squamous intraepithelial lesions [Paper presentation]. 24th International Papillomavirus Conference and Clinical Workshops, Bejing, China. |
 | Jacobs, N., Boniver, J., Hubert, P., & Delvenne, P. (2007). Dendritic Cells: More Than Just Adaptive Immunity Inducers? Current Immunology Reviews, 2, 17-22. doi:10.2174/157339507779802214 Peer Reviewed verified by ORBi |
 | Delvenne, P., Goffin, F., Kridelka, F., Arafa, M., Caberg, J.-H., Herfs, M., Herman, L., Hubert, P., Jacobs, N., Kholod, N., Boniver, J., & Foidart, J.-M. (2007). Le cancer du col de l'utérus: du virus au traitement. Revue Médicale de Liège, 62(S1), 2-6. |
 | Hubert, P., Evrard, B., Delattre, L., Boniver, J., Delvenne, P., Noël, A., Frankenne, F., & Foidart, J.-M. (12 December 2006). Mucoadhesive composition comprising polyacrylate and chemoattractant. |
Herman, L., Hubert, P., Delvenne, P., Boniver, J., Evrard, B., Delattre, L., Frankenne, F., Noël, A., & Foidart, J.-M. (28 June 2006). MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS COMPRISING CHEMOATTRACTANTS. |
| Hubert, P., Caberg, J.-H., Gilles, C., Bousarghin, L., Franzen-Detrooz, E., Boniver, J., & Delvenne, P. (July 2005). E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. Journal of Pathology, 206 (3), 346-355. doi:10.1002/path.1771 Peer Reviewed verified by ORBi |
 | Hubert, P., Bousarghin, L., Greimers, R., Franzen-Detrooz, E., Boniver, J., & Delvenne, P. (June 2005). Production of large numbers of Langerhans' cells with intraepithelial migration ability in vitro. Experimental Dermatology, 14 (6), 469-477. doi:10.1111/j.0906-6705.2005.00299.x Peer Reviewed verified by ORBi |
 | Bousarghin, L., Hubert, P., Franzen, E., Jacobs, N., Boniver, J., & Delvenne, P. (2005). Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells. Journal of General Virology, 86 (Pt 5), 1297-305. doi:10.1099/vir.0.80559-0 Peer Reviewed verified by ORBi |
 | Hallez, S., Simon, P., Maudoux, F., Doyen, J., Noël, J.-C., Beliard, A., Capelle, X., Buxant, F., Fayt, I., Lagrost, A.-C., Hubert, P., Gerday, C., Burny, A., Boniver, J., Foidart, J.-M., Delvenne, P., & Jacobs, N. (July 2004). Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia. Cancer Immunology, Immunotherapy, 53 (7), 642-650. doi:10.1007/s00262-004-0501-4 Peer Reviewed verified by ORBi |
 | Hubert, P., Evrard, B., Maillard, C., Franzen-Detrooz, E., Delattre, L., Foidart, J.-M., Noël, A., Boniver, J., & Delvenne, P. (2004). Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models human papillomavirus-associated (pre)neoplastic epithelial lesions. Antimicrobial Agents and Chemotherapy, 48 (11), 4342-4348. doi:10.1128/AAC.48.11.4342-4348.2004 Peer Reviewed verified by ORBi |
 | Delvenne, P., Hubert, P., & Jacobs, N. (2004). Epithelial metaplasia: an inadequate environment for antitumour immunity? Trends in Immunology, 25 (4), 169-73. doi:10.1016/j.it.2004.02.002 Peer Reviewed verified by ORBi |
Evrard, B., Hubert, P., Delvenne, P., Boniver, J., & Delattre, L. (2004). Development of a hydrogel containing GM-CSF to improve the dendritic cells colonisation of HPV+ epithelium. In Proceedings of Eur conference on drug delivery and pharmaceutical technology. Peer reviewed |
 | Delvenne, P., Hubert, P., Havard, L., Renard, I., Boniver, J., & Jacobs, N. (2003). Modèles expérimentaux in vitro des HPV. In F. Aubin, J. F. Pretet, ... C. Mougin, Papillomavirus Humains (pp. 75-101). Paris, France: Tec & Doc. |
 | Jacobs, N., Renard, I., Al-Saleh, W., Hubert, P., Doyen, J., Kedzia, W., Boniver, J., & Delvenne, P. (2003). Distinct T cell subsets and cytokine production in cultures derived from transformation zone and squamous intraepithelial lesion biopsies of the uterine cervix. American Journal of Reproductive Immunology, 49 (1), 6-13. doi:10.1034/j.1600-0897.2003.01109.x Peer Reviewed verified by ORBi |
 | Giannini, S., Hubert, P., Doyen, J., Boniver, J., & Delvenne, P. (February 2002). Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. International Journal of Cancer, 97 (5), 654-659. doi:10.1002/ijc.10084 Peer Reviewed verified by ORBi |
 | Delvenne, P., Hubert, P., Jacobs, N., Giannini, S., Havard, L., Renard, I., Saboulard, D., & Boniver, J. (2001). The organotypic culture of HPV-transformed keratinocytes: an effective in vitro model for the development of new immunotherapeutic approaches for mucosal (pre)neoplastic lesions. Vaccine, 19 (17-19), 2557-64. doi:10.1016/S0264-410X(00)00489-8 Peer Reviewed verified by ORBi |
 | Hubert, P., Giannini, S., Vanderplasschen, A., Franzen-Detrooz, E., Jacobs, N., Boniver, J., & Delvenne, P. (2001). Dendritic cells induce the death of human papillomavirus-transformed keratinocytes. FASEB Journal, 15 (13), 2521-2523. doi:10.1096/fj.00-0872fje Peer Reviewed verified by ORBi |
 | Jacobs, N., Renard, I., Pisvin, S., Hubert, P., Boniver, J., & Delvenne, P. (2000). IL10 production in cultures of lymphocytes derived from biopsies of normal exocervix, transformation zone and squamous intraepithelial lesion. In J. Monsonego (Ed.), 4th International Multidisciplinary Congress - Eurogin 2000 (pp. 355-362). Pianoro, Italy: International Proceedings Division, Monduzzi Editore. |
 | Hubert, P., van den Brule, F., Giannini, S., Franzen-Detrooz, E., Boniver, J., & Delvenne, P. (1999). Colonization of in vitro-formed cervical human papillomavirus-associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. American Journal of Pathology, 154 (3), 775-784. doi:10.1016/S0002-9440(10)65324-2 Peer Reviewed verified by ORBi |
 | Jacobs, N., Giannini, S., Al-Saleh, W., Hubert, P., Boniver, J., & Delvenne, P. (1999). Generation of T lymphocytes from the epithelium and stroma of squamous pre-neoplastic lesions of the uterine cervix. Journal of Immunological Methods, 223 (1), 123-9. doi:10.1016/S0022-1759(98)00205-1 Peer Reviewed verified by ORBi |
 | Hubert, P., Greimers, R., Franzen-Detrooz, E., Sele, J., Delanaye, P., Boniver, J., & Delvenne, P. (October 1998). In Vitro Propagated Dendritic Cells from Patients with Human-Papilloma Virus-Associated Preneoplastic Lesions of the Uterine Cervix: Use of Flt3 Ligand. Cancer Immunology, Immunotherapy, 47 (2), 81-9. doi:10.1007/s002620050507 Peer Reviewed verified by ORBi |
